United States Files Suit Against Drug Manufacturer Regeneron

United States Files Suit Against Drug Manufacturer Regeneron for Paying Kickbacks Through Co-Pay Foundation (STL.News) –…

Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5B Stock Repurchase

TARRYTOWN, NY (STL.News) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the commencement of an underwritten public…

Regeneron & Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration

TARRYTOWN, NY and AURORA, CO (STL.News) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for…

Regeneron and Sanofi Announce Intent to Restructure Antibody Collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

(STL.News) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced their intent to simplify their…

Regeneron Announces Positive Topline Phase 2 Data with Anti -C5 Antibody Pozelimab in Patients with a Rare Blood Disorder

(STL.News) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced topline data from the pozelimab (REGN3918) Phase…

Regeneron Announces Upcoming Investor Conference Presentations

(STL.News) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows: Guggenheim Healthcare Talks…

Regeneron Colleagues Support 150 Community Organizations During Third Annual Day For Doing Good

(STL.News) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today celebrates its third annual Day for Doing Good,…